These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 5549387)
21. Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. II. Fermentation, isolation and structure. Evans RH; Ax H; Jacoby A; Williams TH; Jenkins E; Scannell JP J Antibiot (Tokyo); 1983 Mar; 36(3):213-6. PubMed ID: 6833141 [TBL] [Abstract][Full Text] [Related]
22. An enzyme inhibitor, panosialin, produced by Streptomyces. II. Chemistry of panosialin, 5-alkylbenzene-1,3-disulfates. Kumagai M; Suhara Y; Aoyagi T; Umezawa H J Antibiot (Tokyo); 1971 Dec; 24(12):870-5. PubMed ID: 5140534 [No Abstract] [Full Text] [Related]
23. Studies on mycotrienin antibiotics, a novel class of ansamycins. II. Structure elucidation and biosynthesis of mycotrienins I and II. Sugita M; Sasaki T; Furihata K; Seto H; Otake N J Antibiot (Tokyo); 1982 Nov; 35(11):1467-73. PubMed ID: 7161185 [No Abstract] [Full Text] [Related]
24. 5,6-Dideoxy-5-oxoerythronolide B, a shunt metabolite of erythromycin biosynthesis. Martin JR; Egan RS Biochemistry; 1970 Aug; 9(17):3439-45. PubMed ID: 5522473 [No Abstract] [Full Text] [Related]
25. KD16-U1, a new metabolite of Streptomyces: isolation and structural studies. Tatsuta K; Tsuchiya T; Mikami N; Umezawa S; Umezawa H; Naganawa H J Antibiot (Tokyo); 1974 Aug; 27(8):579-86. PubMed ID: 4436143 [No Abstract] [Full Text] [Related]
26. Microbial metabolites with tipA promoter inducing activity. II. Geninthiocin, a novel thiopeptide produced by Streptomyces sp. DD84. Yun BS; Hidaka T; Furihata K; Seto H J Antibiot (Tokyo); 1994 Sep; 47(9):969-75. PubMed ID: 7928698 [TBL] [Abstract][Full Text] [Related]
27. Benadrostin, new inhibitor of poly(ADP-ribose) synthetase, produced by actinomycetes. II. Structure determination. Yoshida S; Naganawa H; Aoyagi T; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1988 Aug; 41(8):1015-8. PubMed ID: 3139602 [TBL] [Abstract][Full Text] [Related]
28. Spenolimycin, a new spectinomycin-type antibiotic. II. Isolation and structure determination. McAlpine JB; Brill GM; Spanton SG; Mueller SL; Stanaszek RS J Antibiot (Tokyo); 1984 Dec; 37(12):1519-24. PubMed ID: 6241192 [TBL] [Abstract][Full Text] [Related]
29. Clavamycins, new clavam antibiotics from two variants of Streptomyces hygroscopicus. II. Isolation and structures of clavamycins A, B and C from Streptomyces hygroscopicus NRRL 15846, and of clavamycins D, E and F from Streptomyces hygroscopicus NRRL 15879. Naegeli HU; Loosli HR; Nussbaumer A J Antibiot (Tokyo); 1986 Apr; 39(4):516-24. PubMed ID: 3710913 [TBL] [Abstract][Full Text] [Related]
30. Structure of a new antibiotic curromycin A produced by a genetically modified strain of Streptomyces hygroscopicus, a polyether antibiotic producing organism. Ogura M; Nakayama H; Furihata K; Shimazu A; Seto H; Otake N J Antibiot (Tokyo); 1985 May; 38(5):669-73. PubMed ID: 3839499 [No Abstract] [Full Text] [Related]
31. Selection of a specifically blocked mutant of Streptomyces cinnamonensis: isolation and synthesis of 26-deoxymonensin A. Ashworth DM; Holmes DS; Robinson JA; Oikawa H; Cane DE J Antibiot (Tokyo); 1989 Jul; 42(7):1088-99. PubMed ID: 2753815 [TBL] [Abstract][Full Text] [Related]
32. RS-22A, B and C: new macrolide antibiotics from Streptomyces violaceusniger. II. Physico-chemical properties and structure elucidation. Ubukata M; Morita T; Osada H J Antibiot (Tokyo); 1995 Apr; 48(4):293-9. PubMed ID: 7775265 [TBL] [Abstract][Full Text] [Related]
33. New metabolites, tetrahydrofuran lignans, produced by Streptomyces sp. IT-44. Chiung YM; Hayashi H; Matsumoto H; Otani T; Yoshida K; Huang MY; Chen RX; Liu JR; Nakayama M J Antibiot (Tokyo); 1994 Apr; 47(4):487-91. PubMed ID: 8195049 [No Abstract] [Full Text] [Related]
34. A new antitumor substance, BE-18591, produced by a streptomycete. II. Structure determination. Nakajima S; Kojiri K; Suda H J Antibiot (Tokyo); 1993 Dec; 46(12):1894-6. PubMed ID: 8294249 [No Abstract] [Full Text] [Related]
35. Metabolic products of microorganisms. 208. Haloquinone, a new antibiotic active against halobacteria. II. Chemical structure and derivatives. Krone B; Hinrichs A; Zeeck A J Antibiot (Tokyo); 1981 Dec; 34(12):1538-43. PubMed ID: 7333966 [No Abstract] [Full Text] [Related]
36. The structure of streptonigrone, and a comment on the biosynthesis of the streptonigrin antibiotics. Herlt AJ; Rickards RW; Wu JP J Antibiot (Tokyo); 1985 Apr; 38(4):516-8. PubMed ID: 4008345 [No Abstract] [Full Text] [Related]
37. HS071, a new furan-type cytotoxic metabolite from Streptomyces sp. HS-HY-071. Wang J; Zhang H; Yang X; Zhou Y; Wang H; Bai H J Antibiot (Tokyo); 2008 Oct; 61(10):623-6. PubMed ID: 19168976 [TBL] [Abstract][Full Text] [Related]
38. Microbial transformation of antibiotics. I. Production of lincomycin sulfoxide and 1-demethylthio-1-hydroxylincomycin by S. lincolnensis. Argoudelis AD; Mason DJ J Antibiot (Tokyo); 1969 Jun; 22(6):289-91. PubMed ID: 5810995 [No Abstract] [Full Text] [Related]
39. NUCLEAR MAGNETIC RESONANCE SPECTRAL STUDIES ON SOME ANHYDRO FURANOSE DERIVATIVES. HIRAOKA T; IWASHIGE T; IWAI I Chem Pharm Bull (Tokyo); 1965 Mar; 13():285-91. PubMed ID: 14326506 [No Abstract] [Full Text] [Related]
40. Isolation of neocopiamycin A from Streptomyces hygroscopicus var. crystallogenes, the copiamycin source. Arai T; Uno J; Horimi I; Fukushima K J Antibiot (Tokyo); 1984 Feb; 37(2):103-9. PubMed ID: 6546749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]